Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY.MX) Q2 2024 Earnings

2MayConfirmed

Q3 2023

Q4 2023

Q1 2024

Q2 2024

-38.28

-15.35

7.59

30.52

Details

Expected EPS

-18.9452546654

Actual EPS

-8.827364

Surprise EPS

10.12

Surprise Percent

+53.41%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -8.827364 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.